Handelsbanken Fonder AB - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$700
+6.1%
44,100
+26.0%
0.00%0.0%
Q2 2023$660
+511.1%
35,000
+24.1%
0.00%
+300.0%
Q1 2023$108
-22.9%
28,2000.0%0.00%0.0%
Q4 2022$140
-99.8%
28,200
+67.9%
0.00%0.0%
Q3 2022$80,000
-57.4%
16,800
-59.8%
0.00%0.0%
Q2 2022$188,000
-8.7%
41,800
-3.5%
0.00%0.0%
Q1 2022$206,000
-35.8%
43,3000.0%0.00%
-50.0%
Q4 2021$321,000
+30.5%
43,3000.0%0.00%
+100.0%
Q3 2021$246,000
-13.7%
43,3000.0%0.00%0.0%
Q2 2021$285,00043,3000.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders